Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8238036 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
The risk of developing a second malignancy from neutrons from proton beam therapy of a brain lesion is small (i.e., presumably outweighed by the therapeutic benefit) but not negligible (i.e., potentially greater than the baseline risk). The patient's age at treatment plays a major role.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christina Ph.D., Harald Ph.D.,